innergarm(Korea)

Inclear's Japanese Distributor ‘Alfresa Healthcare’ Showcases Various Medical Products

Wettrust's brand, ‘Inclear,’ is gaining attention as the leading feminine care product in several countries, with particularly high interest and response from Japanese women.

Inclear is imported into Japan through Hanamisui, with general sales in the Japanese market managed by Alfresa Healthcare. Alfresa Healthcare focuses on effectively promoting the excellence of its products through various marketing efforts, including activities at major drugstores such as Welcia Pharmacy Co., Ltd., MCC Co., Ltd., and Kokumin Co., Ltd.

On the 18th, Alfresa Healthcare announced that it would host several medical fairs starting in the second half of 2023, showcasing a wide range of medical products, including Inclear.

In October of last year, products for self-diagnosis and treatment were introduced to consumers through medical fairs and self-medication fairs at the Ichinomiya and Okazaki. In November, a joint medical fair was held at the Nagoya East and Nagoya South, an important event for Matsumoto Kiyoshi.

With the support of the Koku region, the company actively marketed its products by hosting a product exhibition for employees and a medical fair at the Tokai Headquarters. Additionally, in December, the company participated in the Japanese Pharmacy Academic Conference, where it emphasized the expertise and reliability of Inclear products.

These efforts will continue into 2024, with plans to further enhance brand awareness through participation in Care Technology Tokyo in March.

The products handled by the Alfresa Group include prescription drugs, over-the-counter drugs, and medical devices that cater to both domestic and international markets. Alfresa Healthcare has formed a strategic partnership with Hanamisui, the importer of Wettrust products, and continues to expand its global presence and influence in the medical industry through ongoing research and development.

Alfresa Healthcare's active marketing efforts are expected to further accelerate the expansion of Inclear products in the Japanese market.

An official from Hanamisui stated, “Through cooperation with Alfresa Healthcare, we will strengthen our position in Japan's feminine care market and further expand our influence in the global market.”